Author

Lea Wenting Rysavy

Stanford MedicineORCID 0009-0006-2290-6630Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Aastha PaliD· 1 shared Ada WongiD· 1 shared Aidan M. TousleyiD· 1 shared Alexander R. DunniD· 1 shared Anusha K. KalbasiiD· 1 shared Christopher S. SeetiD· 1 shared Crystal Lee MackalliD· 1 shared Deepa Waghray· 1 shared

Activity by Year

2022-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Aastha PalORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologyImmunityPeer-reviewedNov 21, 2025

IL-9 as a naturally orthogonal cytokine with optimal JAK/STAT signaling for engineered T cell therapy

Hua Jiang, Sam P. Limsuwannarot, Kayla R. Kulhanek…·Anusha K. Kalbasi

The paper shows that T cells engineered with IL-9R have better tissue infiltration, stemness, and anti-tumor activity compared to those with an orthogonal IL-9 receptor, due to stronger and more specific JAK/STAT signaling.

17 citationstop 2%

mouseexperimental assay

𝕏 PostBluesky

Synthetic BiologybioRxivPreprintJun 17, 2022

Coopting T cell proximal signaling molecules enables Boolean logic-gated CAR T cell control

Aidan M. Tousley, Maria Caterina Rotiroti, Louai Labanieh…·Robbie G. Majzner

This paper introduces a novel CAR T cell platform using proximal T cell signaling molecules to enable Boolean logic-gated control, improving efficacy and reducing off-tumor toxicity.

6 citations

humanexperimental assay

𝕏 PostBluesky